We have developed three types of experimental systems for the study of SCCL: (1) serially heterotransplanted tumors in athymic nude mice; (2) continuous, clonable cell cultures; and (3) direct clonogenic assays for tumor specimens. These systems have their own individual advantages, applications, and limitations, but these are interrelated and complementary. The study of these systems has greatly aided our understanding of the biology of SCCL, and its relationship to other lung cancers and the APUD cell system. In addition, new markers for SCCL have been identified, such as a creatine kinase and its BB isoenzyme (CK-BB). These cellular markers may have clinical applications, as serum levels of CK-BB are an indicator of tumor burden. Assays for clonogenic tumor cells may permit selection of optimal drug combinations for the treatment of individual tumors. Variant cultures having the morphology of SCCL, but lacking some or all of the other features, have been identified. While our systems have been used primarily for biological studies, they have clinical applications for both diagnostic and therapeutic purposes.
INTRODUCTION
Small cell carcinoma of the lung (SCCL) is one of the most fascinating of human tumors. It is well established as a morphological, biological, and clinical entity, distinct from other lung cancers. Initially, it was considered an undifferentiated tumor that was associated with a variety of paraneoplastic syndromes caused by "ectopic" hormone secretion. The discovery, in the late sixties, that some cells in most of the tumors contained membrane bound, dense core, neurosecretory-like granules [1, 2] led to their inclusion in the amine precursor uptake and decarboxylation (APUD) cell system of Pearse [3] . It was presumed that SCCL and bronchial carcinoids arose from endocrine cells (Kultschitzky) in the normal respiratory mucosa which expressed APUD properties [4] . Pearse postulated that all APUD cells arose from the neural crest, and it was presumed that Kultschitzky cells and SCCL had a different embryological origin from the rest of the endodermally derived respiratory mucosa and non-SCCL lung cancers. However, as we learned more facts about SCCL, it became even more enigmatic. Why did SCCL secrete some APUD cell hormones frequently, and others seldom or not at all? Why did some SCCL tumors contain non-SCCL elements, and how could some SCCL tumors undergo morphological conversion to other tumor types, especially as the two groups were supposed to be derived from different germ layers? Do all SCCL cells express APUD properties, or only the small percentage that have visible neurosecretory granules? Is SCCL a homogenous group of tumors, or can certain non-SCCL tumors mimic SCCL morphologically? There are few endocrine cells in the normal adult respiratory tree, and the premalignant and early neoplastic changes of SCCL are not well documented. Despite a few reports [5, 6] , suitable animal models are not generally available or well studied. To further our understanding of the biology of SCCL, we undertook the establishment and characterization of tissue culture cell lines from human SCCL tumors.
THE BASIC APPROACH Our basic approach was threefold: (1) heterotransplant lung tumors into athymic nude mice and subpassage them; (2) establish continuous, clonable cultures of lung cancers free of contamination by stromal cells and prove that these replicating cell lines were malignant and had biochemical and morphologic features consistent with SCCL; (3) clone lung cancer specimens directly in semi-solid medium. These approaches have individual advantages and disadvantages, and are used for different studies. For these reasons, they are discussed separately. However, as will be shown later, they are not entirely independent, and some studies require the use of more than one type of approach.
While our studies concentrated on SCCL, tissue culture lines from non-SCCL lung cancers were also established, and their properties were compared and contrasted with those of the SCCL lines. Cell lines were established from primary and metastatic lung tumors from treated and untreated patients. Most non-SCCL lung cancers were surgically resected specimens from untreated patients. Because SCCL and mesotheliomas are seldom resected, their cell lines were established from metastatic lesions of treated and untreated patients, and included biopsies of bone, nodes, subcutaneous, brain, and liver metastases and malignant effusions. Because SCCL are particularly susceptible to damage by handling procedures, the most successful specimens were those that required the least mechanical or chemical manipulations. These included malignant effusions and bone marrow aspirates. The cells in these sites were relatively viable, and were already disaggregated into single cells or small clusters. In addition, tumor cells in effusions may be regarded as already having been adapted to "in vivo culture" conditions, and were more easily adaptable to in vitro culture. The least successful specimens were those coming from solid lesions such as node or subcutaneous metastases. These lesions frequently had extensive areas of necrosis, and required considerable disaggregation, either mechanically or by trypsinization.
HETEROTRANSPLANTATIONS OF SCCL TUMORS
Athymic nude mice are suitable recipients for the heterotransplantation of several, but not all, human tumors [7, 8] . The work of several investigators indicates that nude mice have some degree of resistance to heterotransplantation, and that such resistance may be due to components of the immune system such as natural killer (NK) cells [9, 10] . We compared and contrasted the subcutaneous (sc) and intracranial (ic) inoculation of SCCL tumors and cultures [11] . SCCL tumor specimens had a take rate of 42 percent when inoculated sc, and 89 percent when inoculated ic. The sc tumors grew as expansile, seldom invasive, non-metastasizing, and non-lethal tumors. Failure to metastasize was not due to lack of vascular invasion, as tumor emboli were present in the veins draining the tumors. In contrast to sc tumors, ic tumors required 10- successfully in it for periods of 3-15 weeks, and 10 of these specimens were established as continuous cultures [13] . In contrast, the vast majority of non-SCCL lung cancers and stromal cells do not replicate in HITES medium. Thus, use of this medium is a highly selective method for the propagation of SCCL cells, and we have used it for the rapid augmentation of tumor cells in specimens not otherwise adequate for drug testing by clonogenic assays. In addition, HITES medium is useful for the purification and identification of peptides and other SCCL cell products because, in contrast to serum supplemented medium, it contains relatively few complex molecules. We are currently exploring its use for the selective growth of the precursor cells of SCCL present in the normal respiratory tree. In addition, we would like to develop selective growth formulas for the other histologic types of lung cancer.
SCCL AND THE APUD CELL SYSTEM
The identification of neurosecretory granules and serotonin in some SCCL tumors led Pearse to include them in his APUD cell system [3] . APUD cells are a diffuse collection of cells scattered in many organs and having amine handling properties. Pearse originally proposed that all APUD cells were derived from the neural crest, but has recently modified his views [18] in the face of overwhelming evidence to the contrary. We have summarized the evidence that SCCL and their presumptive precursor cells are, like the rest of the respiratory tree, derived from endoderm [19] . This evidence includes failure to demonstrate the neuroectodermal origin of the respiratory and GI endocrine cells, the relatively frequent presence of tumors of mixed SCCL and other histologies, the in vivo and in vitro conversion of SCCL to other tumor types, and the occasional expression of APUD cell properties by other histological types of lung cancer.
Despite the continuing controversy regarding the APUD cell concept, SCCL cells express the full range of APUD cell properties. While studies of clinical and autopsy specimens [20, 21] indicate a wide range of expression, SCCL cultures express them uniformly [12] . Thus, all cultures have easily identifiable neurosecretory granules and very high levels of the key APUD cell enzyme L-dopa decarboxylase (DDC, EC 4.1.1.28). They fluoresce after exposure to formaldehyde vapor (indicating amine precursor uptake and, perhaps, decarboxylation), and most secrete one or more polypeptide hormones [12, 22, 23] . Analysis of more than 130 clones of seven SCCL cultures indicated that high levels of DDC were retained in all cultures [AFG et al, unpublished data]. In contrast, the clones had multiple patterns of polypeptide secretion [24] .
CREATINE KINASE-A NEW MARKER FOR SCCL SCCL tumors and cultures are characterized by very high levels of creatine kinase (CK, EC 2.7.3.2) predominantly in the form of its BB isoenzyme (CK-BB) [25] . Electrophoretic analyses of CK isoenzymes indicated that CK levels in SCCL were quantitatively but not qualitatively different from those in normal lung and other lung cancers. Because CK-BB is measured by a sensitive radioimmunoassay, while total CK activity is measured enzymatically, we determined serum levels of CK-BB in 67 untreated patients having SCCL. Elevated levels were present in 16/41 (39 percent) with extensive-stage disease, but in none of 26 (0 percent) of patients with limited-stage disease. Our preliminary findings [DNC et al, unpublished observations] indicate that elevated serum levels reflect tumor bulk, and are present in only a small percentage of patients having metastases in one site, while 100 percent of patients with metastases to four or more sites have elevated levels. Serum levels may also be used to monitor response to therapy, and relapse of tumor after therapy induced remission.
SCCL TUMOR VARIANTS While we have indicated above that SCCL cultures uniformly express APUD cell properties and high levels of CK-BB, certain cultures, established from patients having classical SCCL by light microscopic criteria, lacked these properties. Some of the variants retained SCCL morphology and growth characteristics in culture, while others did not. Ultrastructure of these tumors indicated that they consisted of primitive cells lacking neurosecretory granules, but they had numerous desmosomes and prominent bundles of filaments. By conventional ultrastructural criteria they would be classified as poorly differentiated squamous cell carcinomas. Because they have many of the features of the basal cells in the respiratory mucosa, the possibility that they represent true undifferentiated tumors or perhaps "stem" cell tumors must be considered. While these tumors are treated as SCCL, we do not as yet know whether their response to cytotoxic therapy is similar to that of SCCL. MORPHOLOGICAL AND BIOCHEMICAL CHANGES IN SCCL CELL LINES SCCL tumors frequently undergo changes in morphology after therapy [26, 27] , especially to large cell carcinoma, although virtually any form of lung cancer may be represented. The change may be partial or complete. Morphological change is accompanied by loss of the biochemical characteristics of SCCL. Similar changes have been observed in our cell lines, including long-term cultures and heterotransplants passaged many times [19, 28] . In vitro changes are accompanied by loss of all APUD markers, but high levels of CK-BB are retained, indicating discordant regulation of the two enzyme markers CK and DDC [25] . Altered morphology in vitro is accompanied by rapid growth, high cloning efficiencies, loss of typical SCCL morphology in in vitro culture and, sometimes, by an increase in DNA content. Our interpretation of these changes is discussed below.
THE NATURE OF SCCL AND ITS RELATIONSHIP TO
OTHER LUNG CANCERS Our lung cancer cell lines, and similar ones established by others [22, 23] , have greatly aided our understanding of a complex tumor. Because of the constant biochemical and ultrastructural characteristics of SCCL, we regard it as a differentiated tumor, closely related to other polypeptide secreting APUD tumors. We presume it arises either directly from endocrine cells in the respiratory tree, or, more likely, from common precursor cells committed to differentiation along endocrine lines [19] . While the function of the Kultschitzky cells are not known, at least two polypeptides, bombesin and calcitonin [29, 30] , are present in them. We presume that their function is the elaboration of multiple polypeptides that have nutritional or differentiational effects on neighboring mucosal cells. Whether one type of endocrine cell exists in the lung or whether multiple functional forms occur is a moot point. We further presume that elaboration of hormones by SCCL is an extension of the function of their normal counterparts, and should not be regarded as "ectopic." Altered morphology to large cell carcinoma with loss of biochemical and ultrastructural characteristics should be regarded as loss of differentiation. The presence of other non-SCCL elements, both before therapy and, more frequently, after therapy, suggests a close interrelationship between all forms of bronchogenic carcinoma. Their presence cannot be explained on the basis of two separate embryological origins for lung cancers. These changes may have clinical significance, as SCCL tumors are therapy sensitive, while other forms of lung cancer are resistant. Human tumor cell lines have greatly increased our knowledge and understanding of SCCL. They also have clinical applications, both for diagnostic and therapeutic purposes.
